Cotransin TFA is a cyclic ester peptide and a Sec61 translocator binder with signal sequence-selective activity to inhibit co-translational protein translocation. Cotransin TFA inhibits the biogenesis of a subset of secretory and membrane proteins in a signal peptide-dependent manner. Cotransin TFA is applicable for cancer-related research [1] [2].
In Vitro, Cotransin TFA inhibits the biogenesis of a subset of secretory proteins and membrane proteins in a signal peptide-dependent manner[1][2].
References:
[1]. Choi I, et al. Cotransin induces accumulation of a cytotoxic clusterin variant that cotranslationally rerouted to the cytosol. Exp Cell Res. 2013;319(8):1073-1082.
[2]. Wenzell NA, et al. Global signal peptide profiling reveals principles of selective Sec61 inhibition. Nat Chem Biol. 2024;20(9):1154-1163.
In Vitro, Cotransin TFA inhibits the biogenesis of a subset of secretory proteins and membrane proteins in a signal peptide-dependent manner[1][2].
References:
[1]. Choi I, et al. Cotransin induces accumulation of a cytotoxic clusterin variant that cotranslationally rerouted to the cytosol. Exp Cell Res. 2013;319(8):1073-1082.
[2]. Wenzell NA, et al. Global signal peptide profiling reveals principles of selective Sec61 inhibition. Nat Chem Biol. 2024;20(9):1154-1163.